Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Rathke’s cleft-like cysts arise from Isl1 deletion in murine pituitary progenitors
Michelle L. Brinkmeier, … , Flávio S.J. de Souza, Sally A. Camper
Michelle L. Brinkmeier, … , Flávio S.J. de Souza, Sally A. Camper
Published May 26, 2020
Citation Information: J Clin Invest. 2020;130(8):4501-4515. https://doi.org/10.1172/JCI136745.
View: Text | PDF
Research Article Development Genetics

Rathke’s cleft-like cysts arise from Isl1 deletion in murine pituitary progenitors

  • Text
  • PDF
Abstract

The transcription factor ISL1 is expressed in pituitary gland stem cells and the thyrotrope and gonadotrope lineages. Pituitary-specific Isl1 deletion causes hypopituitarism with increased stem cell apoptosis, reduced differentiation of thyrotropes and gonadotropes, and reduced body size. Conditional Isl1 deletion causes development of multiple Rathke’s cleft-like cysts, with 100% penetrance. Foxa1 and Foxj1 are abnormally expressed in the pituitary gland and associated with a ciliogenic gene-expression program in the cysts. We confirmed expression of FOXA1, FOXJ1, and stem cell markers in human Rathke’s cleft cyst tissue, but not craniopharyngiomas, which suggests these transcription factors are useful, pathological markers for diagnosis of Rathke’s cleft cysts. These studies support a model whereby expression of ISL1 in pituitary progenitors drives differentiation into thyrotropes and gonadotropes and without it, activation of FOXA1 and FOXJ1 permits development of an oral epithelial cell fate with mucinous cysts. This pituitary-specific Isl1 mouse knockout sheds light on the etiology of Rathke’s cleft cysts and the role of ISL1 in normal pituitary development.

Authors

Michelle L. Brinkmeier, Hironori Bando, Adriana C. Camarano, Shingo Fujio, Koji Yoshimoto, Flávio S.J. de Souza, Sally A. Camper

×

Figure 6

ISL1 regulates multiple aspects of pituitary gland development.

Options: View larger image (or click on image) Download as PowerPoint
ISL1 regulates multiple aspects of pituitary gland development.
ISL1 reg...
ISL1 regulates growth of Rathke’s pouch. ISL1 expression is initially activated throughout the pouch (E10.5) (41). By E11.5, ISL1 expression is restricted to the ventral aspect of Rathke’s pouch (green), where cells begin to differentiate and express CGA. This ISL1 domain is juxtaposed ventrally by FOXA1 expression in the nearby oral ectoderm and dorsally by cyclin D1 (CCND1, yellow) expression in proliferating progenitor cells transitioning from the G1 to the S phase. In the absence of ISL1 expression, the domain of cyclin D1 expression is expanded and there are ectopic sites of apoptosis (black). ISL1 stimulates specification of gonadotrope and thyrotrope lineages by elevating expression of NR5A1 and FOXL2. ISL1-deficient pituitaries have reduced expression of NR5A1 and FOXL2, but no obvious change in GATA2 or GATA3 expression. The reduction in lineage-specific transcription factor gene expression is associated with differentiation of very few thyrotropes (yellow) and gonadotropes (blue) cells at birth. ISL1 suppresses SOX2-expressing progenitors from adopting alternate cell fates. Loss of ISL1 leads to abnormal expression of FOXA1 (red), atypical localization of GATA3 in the nucleus (blue), and activation of p21 expression (CDKN1A, yellow), which is associated with cell cycle exit (G0). These cells maintain FOXA1 expression, activate FOXJ1, and execute a ciliogenic, mucinous cell fate, resulting in ciliated and nonciliated RCCs.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts